Analysts downgrade Kraft Heinz and Biogen as market outlook shifts

benzinga.com October 31, 2024, 05:01 PM UTC

Analysts have downgraded several major companies. Deutsche Bank lowered Kraft Heinz's rating from Buy to Hold, reducing the price target from $39 to $35. Kraft Heinz shares closed at $33.73. Morgan Stanley downgraded Biogen from Overweight to Equal-Weight, cutting the price target from $285 to $204. Biogen shares ended at $181.18. JP Morgan downgraded Brinker International from Overweight to Neutral but raised the price target from $67 to $100. Bernstein downgraded Arm Holdings from Market Perform to Underperform, maintaining a $100 price target.


With a significance score of 3, this news ranks in the top 55% of today's 19283 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 8000 minimalists.